Review Articles

Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
Department of Medical Sciences, Internal Medicine and Hypertension Division, University of Torino, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Italy; Rete Oncologica Piemontese, Italy
University of L’Aquila, MeSVA Department, San Salvatore Hospital, Division of Internal Medicine & Nephrology, Coppito, Italy
Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Germany
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
Department of Clinical Therapeutics, University of Athens School of Medicine, Greece
Medizinische Klinik, Abteilung Innere Medizin V, Universitätsklinikum Heidelberg und National Centrum für Tumorerkrankungen (NCT), Heidelberg, Germany
“Seràgnoli” Institute of Hematology and Medical Oncology, University of Bologna, Italy
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
1. Medical Department and Oncology, Wilhelminenspital Wien, Austria
Department of Medicine, Imperial College London, UK
Department of Hematology, Domaine University, Liege, Belgium
Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Germany
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
Department of Internal Medicine II, University Hospital of Würzburg, Germany
Department of Hematology, Rotterdam, the Netherlands
Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Germany
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2018.191288